TrialJournal of the American Heart Association2018

Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial.

Jenna L Pinchbeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.